483
Celltrion Pharm, Inc.Celltrion Pharm, Inc. – FDA 483, Sep 14, 2023
Record Details
An FDA inspection of Celltrion Pharm, Inc. in Cheongju-si, Korea, a drug manufacturer, revealed significant deficiencies in their quality management system. The firm failed to adequately establish procedures for finished device acceptance, corrective and preventive actions, and management review. These issues indicate a lack of robust controls over product quality and system oversight.
View Company Profile
ID · 63dbea5b-92ee-4735-a241-d0e54a9509ac
Other documents for Celltrion Pharm, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.